Author:
Bøgelund Mette,Jørgensen Nils B.,Madsbad Sten,Spanggaard Maria,Panton Ulrik H.,Pedersen Mikkel H.,Johansen Pierre
Abstract
Abstract
Purpose
We aimed to estimate the total cost of bariatric surgery in Denmark.
Materials and Methods
The study population included all Danish citizens ≥ 18 years who had received bariatric surgery, identified in the Danish National Patient Register in the period from 2002 to 2018. Patients who had received bariatric surgery were matched with three controls on gender, year of birth, and region of residence. A difference-in-difference approach was used to estimate the healthcare costs attributable to bariatric surgery from 3 years before to 5 years after surgery.
Results
Total healthcare costs for cases receiving bariatric surgery during the first 5 years following surgery amounted to EUR 32,899, and EUR 16,651 for their matched controls. Thereby, the difference in total healthcare costs (EUR 16,248) between persons receiving bariatric surgery and their matched controls was 2.2 times the DRG rate for the surgery itself (EUR 7387).
Moreover, the results suggest that receiving bariatric surgery led to a total increase in gross earnings of EUR 5970 (5%) and a total reduction in receipt of transfer payments of EUR 4488 (12%) in the period up until 5 years after surgery.
Conclusion
The results showed a significant and persistent increase in healthcare costs for people with obesity receiving bariatric surgery during the first 5 years after surgery. We also found that bariatric surgery was associated with increased attachment to the labor market.
Graphical abstract
Funder
Novo Nordisk North West Europe Pharmaceuticals
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery
Reference15 articles.
1. Pineda E, Sanchez-Romero LM, Brown M, Jaccard A, Jewell J, Galea G, et al. Forecasting future trends in obesity across Europe: the value of improving surveillance. Obes Facts Karger Publishers. 2018;11:360–71.
2. Sundhedsstyrelsen, Statens Institut for Folkesundhed. Danskernes Sundhed - Tal fra Den Nationale Sundhedsprofil [Internet]. 2017 [cited 2019 Mar 15]. Available from: http://www.danskernessundhed.dk/
3. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. Khaw K-T, editor. PLoS Med. 2014;11:e1001673.
4. Yuen M, Earle RL, Kadambi N, Brancale J, Lui DT, Kahan SI, et al. A systematic review and evaluation of current evidence reveals 236 obesity-associated disorders (ObAD). 2016.
5. Martinussen C, Bojsen-Moller KN, Svane MS, Dejgaard TF, Madsbad S. Emerging drugs for the treatment of obesity. Expert Opin Emerg Drugs. 2017;22:87–99.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献